SCHEMBL62179

SCHEMBL62179

O=C=Nc1cccc(Oc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.46
MAOB P27338 2/20 0.46
LTA4H P09960 1/20 0.44
TSHR P16473 1/20 0.44
HDAC8 Q9BY41 1/20 0.41
MAPK1 P28482 2/20 0.41
MITF O75030 2/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
PTGS1 P23219 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
FURIN P09958 1/20 0.40
GAA P10253 2/20 0.39
KMT2A Q03164 2/20 0.39
GSTP1 P09211 1/20 0.39
LMNA P02545 1/20 0.39
MAOA P21397 1/20 0.39
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29808710 0.94 TDP1 (0.44) AKR1C3MAOBTSHRMAPK1MITF
SCHEMBL5104173 0.94 TDP1 (0.44) AKR1C3MAOBTSHRMAPK1MITF
SCHEMBL7133728 0.92 CYP3A4 (0.44) AKR1C3MAOBTSHRMAPK1MITF
SCHEMBL1861293 0.91 FURIN (0.46) AKR1C3MAOBTSHRMAPK1MITF
SCHEMBL8143862 0.89 FURIN (0.41) AKR1C3MAOBMAPK1MITFALDH1A1
SCHEMBL22966342 0.88 MAPT (0.39) AKR1C3MAOBLTA4HTSHRHDAC8
SCHEMBL17576543 0.84 FURIN (0.37) AKR1C3MAOBHDAC8MAPK1MITF
SCHEMBL8341982 0.84 HTT (0.54) MITFALDH1A1POLBHTTTDP1
SCHEMBL16765731 0.83 CYP3A4 (0.43) AKR1C3MAOBMAPK1ALDH1A1HTT
SCHEMBL7136291 0.83 FURIN (0.53) AKR1C3MAOBTSHRMAPK1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713378-A1 ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS Covestro Deutschland AG (DE) 2026-03-25 EP disclosed
EP-3774961-B1 ADDUCTS OF AMINE CATALYSTS FOR PRODUCING ISOCYANURATE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2025-01-15 EP disclosed
WO-2024236000-A1 ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2024-11-21 WO disclosed
EP-4464727-A1 ESTERIFIED ETHANOLAMINES FOR THE PREPARATION OF ISOCYANURATE POLYMERS Covestro Deutschland AG (DE) 2024-11-20 EP disclosed
US-12145913-B2 Inhibition of Olig2 activity Curtana Pharmaceuticals, Inc. (US) 2024-11-19 US disclosed
US-20240150515-A1 Low Viscosity Catalyst Compositions for Producing Isocyanurate Polymers COVESTRO DEUTSCHLAND AG (DE) 2024-05-09 US disclosed
EP-4298140-A1 LOW VISCOSITY CATALYST COMPOSITIONS FOR PRODUCING ISOCYANURATE POLYMERS Covestro Deutschland AG (DE) 2024-01-03 EP disclosed
CN-116917364-A Low viscosity catalyst composition for producing isocyanurate polymers 科思创德国股份有限公司 2023-10-20 CN disclosed
CN-112020525-B Adducts of amine catalysts for preparing isocyanurate polymers 科思创知识产权两合公司 2023-05-16 CN disclosed
US-20220363809-A1 POLYMERIZABLE COMPOSITIONS FOR PREPARING POLYISOCYANURATE-BASED PLASTICS HAVING EXTENDED WORKLIFE COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-11-17 US disclosed
WO-2003080625-A1 THIOPYRIMIDINE AND ISOTHIAZOLOPYRIMIDINE KINASE INHIBITORS ABBOTT LABORATORIES (US) 2003-10-02 WO disclosed
US-20030181468-A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors ABBOTT LABORATORIES 2003-09-25 US disclosed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
CN-1354747-A 2-amino-4H-3, 1-benzoxazin-4-one derivatives for the treatment of obesity ALIZYME THERAPEUTICS LTD (GB) 2002-06-19 CN disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed
US-4514210-A Herbicidally active methyl-substituted tetrahydro-2-pyrimidinone derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-04-30 US disclosed
US-4435416-A BACTERICIDES; POSTEMERGENCE HERBICIDES CHEVRON RESEARCH COMPANY (US) 1984-03-06 US disclosed
US-4402731-A Herbicidally active novel substituted tetrahydropyrimidinones NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1983-09-06 US disclosed
EP-0086411-A2 Methyl-substituted tetrahydro-2-pyrimidinone derivatives, process for their preparation and their use as herbicides, as well as intermediates for their preparation NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1983-08-24 EP disclosed
EP-0058868-A1 Derivatives of tetrahydropyrimidinon, process for their preparation and herbicides containing those derivatives as active products NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1982-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 AKR1C3 2353/4885MAOB 1001/4885LTA4H 2321/4885
US-20030181468-A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors ABL1, ERBB2, LCK AKR1C3 3667/4885MAOB 3440/4885LTA4H 4209/4885
US-12145913-B2 Inhibition of Olig2 activity POU2F2, POU2F1, PLP2 AKR1C3 4478/4885MAOB 2201/4885LTA4H 4666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.